BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2030667)

  • 21. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the mortality of A-bomb survivors. 5. Radiation dose and mortality, 1950-1970.
    Jablon S; Kato H
    Radiat Res; 1972 Jun; 50(3):649-98. PubMed ID: 5030091
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Summary of the latest reports on remote sequelae of the atomic explosions in Hiroshima and Nagasaki].
    Akimoto S; Kusano N; Nakamura H; Shiga H
    Orv Hetil; 1966 Aug; 107(33):1537-43. PubMed ID: 5945669
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality.
    Kato H; Schull WJ
    Radiat Res; 1982 May; 90(2):395-432. PubMed ID: 7079470
    [No Abstract]   [Full Text] [Related]  

  • 26. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
    Matsuura M; Hayakawa N; Shimokata H
    Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation of Hiroshima and Nagasaki builds foundation for risk estimates.
    Ketchum LE
    J Nucl Med; 1985 Aug; 26(8):833-6. PubMed ID: 3897479
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised dose estimates at Hiroshima and Nagasaki.
    Loewe WE; Mendelsohn E
    Health Phys; 1981 Oct; 41(4):663-6. PubMed ID: 7309523
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival rate of leukemia in Hiroshima and Nagasaki (based on the leukemia registry at Atomic Bomb Casualty Commission (ABCC)].
    Yoshimura T; Ishimaru T
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):193. PubMed ID: 1169522
    [No Abstract]   [Full Text] [Related]  

  • 33. Dietary factors and cancer mortality among atomic-bomb survivors.
    Sauvaget C; Kasagi F; Waldren CA
    Mutat Res; 2004 Jul; 551(1-2):145-52. PubMed ID: 15225589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced leukemia: lessons from history.
    Finch SC
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):109-18. PubMed ID: 17336261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants.
    Kato H; Brown CC; Hoel DG; Schull WJ
    Radiat Res; 1982 Aug; 91(2):243-64. PubMed ID: 7100400
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survey of the newest reports on late damages caused by the atomic bomb explosions in Hiroshima and Nagasaki (1965)].
    Akimoto S; Kusano N; Nakamura H; Shiga H
    Dtsch Gesundheitsw; 1966 Jun; 21(26):1206-11. PubMed ID: 5955616
    [No Abstract]   [Full Text] [Related]  

  • 39. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996).
    Little MP
    Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
    Zhunussova T; Matsuura M; Hayakawa N
    Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.